Manish Kumar is Associate Professor at the University of Delhi South Campus, New Delhi, India. He did his PhD from CSIR-Institute of Microbial Technology, Chandigarh India. During PhD he developed machine learning based tools for functional annotation of proteomes. His research group works on multiple problems/fields, which are important for translational research. One of his research interests is analysis of microbial genomes and proteomes using bioinformatics, chemi-informatics, phylogenomics and machine-learning tools to understand mechanisms behind evolution and spread of virulence and antibiotic resistance among microbes. His group also studies functional interactions between proteins in metabolic and signaling pathways or protein complexes to predict potential targets for diagnostics, vaccines and/or therapeutics. They use molecular modeling and computer-based simulation techniques for structure-based drug designing, translational medicine and protein family-based approaches to repurpose the known drugs and/or identify novel drugs. He serves as Editorial Board member for Scientific Reports and Frontiers in Genetics.
Manish Kumar is Associate Professor at the University of Delhi South Campus, New Delhi, India. He did his PhD from CSIR-Institute of Microbial Technology, Chandigarh India. During PhD he developed machine learning based tools for functional annotation of proteomes. His research group works on multiple problems/fields, which are important for translational research. One of his research interests is analysis of microbial genomes and proteomes using bioinformatics, chemi-informatics, phylogenomics and machine-learning tools to understand mechanisms behind evolution and spread of virulence and antibiotic resistance among microbes. His group also studies functional interactions between proteins in metabolic and signaling pathways or protein complexes to predict potential targets for diagnostics, vaccines and/or therapeutics. They use molecular modeling and computer-based simulation techniques for structure-based drug designing, translational medicine and protein family-based approaches to repurpose the known drugs and/or identify novel drugs. He serves as Editorial Board member for Scientific Reports and Frontiers in Genetics.